• Canada's Medical Marijuana Regulations, An Overview

    26 August 2015

    Read More

Regulatory Recon: FDA Warns of Severe Joint Pain With DPP-4 Inhibitors (31 August 2015)

31 August 2015

Read More

Regulatory Recon: FDA Spells Out Biosimilar Naming Rules, Second PCSK9 Inhibitor Approved (28 August 2015)

28 August 2015

Read More

Bringing Structure to Substance Information

28 August 2015

Read More

European Regulatory Roundup: EMA Posts Recommendations on Advanced-Therapy Medicinal Product Classifications (27 August 2015)

27 August 2015

Read More

FDA Issues Long-Awaited Biological Product Naming Guidance

27 August 2015

Read More

Regulatory Recon: FDA Responds to Congress on Opioid Black Boxes (27 August 2015)

27 August 2015

Read More

Regulatory Recon: FDA Gives Industry More Time to Comment on Quality Metrics (26 August 2015)

26 August 2015

Read More

Are You a Good Witch, or a Bad Witch?

26 August 2015

Read More

Quality Metrics: Industry Reaction to FDA's Draft Guidance

25 August 2015

Read More

Asia Regulatory Roundup: Australia Recommends First Pharmacy-Level Substitution of mAb Biosimilar (25 August 2015)

25 August 2015

Read More